Surgical Science Sweden Stock Performance

SUSRF Stock  USD 2.84  0.57  16.72%   
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Surgical Science are completely uncorrelated. At this point, Surgical Science Sweden has a negative expected return of -1.26%. Please make sure to validate Surgical Science's risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and day median price , to decide if Surgical Science Sweden performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Surgical Science Sweden has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Begin Period Cash Flow87.2 M
Total Cashflows From Investing Activities-2.7 B
  

Surgical Science Relative Risk vs. Return Landscape

If you would invest  858.00  in Surgical Science Sweden on November 18, 2025 and sell it today you would lose (574.00) from holding Surgical Science Sweden or give up 66.9% of portfolio value over 90 days. Surgical Science Sweden is currently producing negative expected returns and takes up 7.6554% volatility of returns over 90 trading days. Put another way, 68% of traded pink sheets are less volatile than Surgical, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Surgical Science is expected to under-perform the market. In addition to that, the company is 10.14 times more volatile than its market benchmark. It trades about -0.16 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.16 per unit of volatility.

Surgical Science Target Price Odds to finish over Current Price

The tendency of Surgical Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 2.84 90 days 2.84 
about 77.42
Based on a normal probability distribution, the odds of Surgical Science to move above the current price in 90 days from now is about 77.42 (This Surgical Science Sweden probability density function shows the probability of Surgical Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Surgical Science has the beta coefficient that is very close to zero. This usually implies the returns on DOW JONES INDUSTRIAL and Surgical Science do not appear to be reactive. Additionally It does not look like Surgical Science's alpha can have any bearing on the current valuation.
   Surgical Science Price Density   
       Price  

Predictive Modules for Surgical Science

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Surgical Science Sweden. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.142.8410.50
Details
Intrinsic
Valuation
LowRealHigh
0.183.5611.22
Details
Naive
Forecast
LowNextHigh
0.042.059.70
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.513.073.63
Details

Surgical Science Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Surgical Science is not an exception. The market had few large corrections towards the Surgical Science's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Surgical Science Sweden, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Surgical Science within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.00
β
Beta against Dow Jones0.00
σ
Overall volatility
1.86
Ir
Information ratio -0.17

Surgical Science Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Surgical Science for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Surgical Science Sweden can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Surgical Science generated a negative expected return over the last 90 days
Surgical Science has high historical volatility and very poor performance
About 33.0% of the company outstanding shares are owned by corporate insiders

Surgical Science Fundamentals Growth

Surgical Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Surgical Science, and Surgical Science fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Surgical Pink Sheet performance.

About Surgical Science Performance

By analyzing Surgical Science's fundamental ratios, stakeholders can gain valuable insights into Surgical Science's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Surgical Science has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Surgical Science has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Surgical Science Sweden AB develops and markets virtual reality simulators for evidence-based laparoscopic and endoscopic training. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden. Surgical Science is traded on OTC Exchange in the United States.

Things to note about Surgical Science Sweden performance evaluation

Checking the ongoing alerts about Surgical Science for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Surgical Science Sweden help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Surgical Science generated a negative expected return over the last 90 days
Surgical Science has high historical volatility and very poor performance
About 33.0% of the company outstanding shares are owned by corporate insiders
Evaluating Surgical Science's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Surgical Science's pink sheet performance include:
  • Analyzing Surgical Science's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Surgical Science's stock is overvalued or undervalued compared to its peers.
  • Examining Surgical Science's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Surgical Science's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Surgical Science's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Surgical Science's pink sheet. These opinions can provide insight into Surgical Science's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Surgical Science's pink sheet performance is not an exact science, and many factors can impact Surgical Science's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Surgical Pink Sheet analysis

When running Surgical Science's price analysis, check to measure Surgical Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgical Science is operating at the current time. Most of Surgical Science's value examination focuses on studying past and present price action to predict the probability of Surgical Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgical Science's price. Additionally, you may evaluate how the addition of Surgical Science to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Transaction History
View history of all your transactions and understand their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories